Navigation Links
Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting
Date:12/3/2008

SOUTH SAN FRANCISCO, Calif., Dec. 3 /PRNewswire/ -- Portola Pharmaceuticals, a biopharmaceutical company developing innovative drugs that provide significant advances in cardiovascular disease, inflammatory disease and cancer, today announced that data related to the Company's series of novel compounds that inhibit spleen tyrosine kinase (Syk) and its novel universal Factor Xa inhibitor antidote will be presented at the annual meeting of the American Society of Hematology (ASH) at the Moscone Center in San Francisco during December 6-9, 2008.

Portola's Syk inhibitor program is focused on developing specific oral inhibitors of this key signaling pathway, which modulate inflammation, certain cancers and thrombosis. The Company plans to study its compounds initially in rheumatoid arthritis and non-Hodgkin's Lymphoma and eventually intends to explore their potential in other inflammatory diseases and cancers. Portola is developing its universal Factor Xa inhibitor antidote to neutralize the effect of small molecule Factor Xa inhibitors in patients experiencing major bleeding and for patients undergoing emergent or elective surgery.

Details of the ASH presentations are below and full abstracts can be viewed on the ASH website at http://www.hematology.org.

Syk Inhibitor Program

"Specific Inhibition of Syk is Sufficient to Disrupt Proliferation and Survival of Non-Hodgkin's Lymphoma Cell Lines without Concomitant Inhibition of JAK" (abstract # 1794)

Saturday, December 6, 5:30 PM

Hall A (Moscone Center)

"PRT060318, a Novel Syk Inhibitor, Prevents Heparin-Induced Thrombocytopenia in a Transgenic Mouse Model" (abstract # 269)

Monday, December 8, 7:00 AM

3007-3009-3011 - West (Moscone Center)

"Specific Pharmacological Targeting of the Syk Kinase Activity in Platelets: A Nove
'/>"/>

SOURCE Portola Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
2. Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation
3. Novel Technology Breaks Through Cancer Pain
4. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
5. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
6. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
7. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
8. NIST team develops novel method for nanostructured polymer thin films
9. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
10. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
11. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ...maceutical company focused on endocrine therapy an... Drug Administration (FDA) has granted Fast Track ...ibitor compound, perifosine (KRX-0401), for the tr...eryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), i...
(Date:12/1/2009)...omon announced that he has joined Carolina Eyecare...e at www.DrKerrySolomon.com , which was developed...oven LASIK, lens implant, and cataract surgery exp... substantial contributions to improving vision cor...Surgeons, which screens LASIK surgeons based upon ...
(Date:12/1/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Emerging Clinical Trial Locations - Eas...thcare and regulatory environment ,, http://w...al-Locations---Eastern-Europe-Market-dynamics-and-....html ,, Over the last decade pharmaceutical a...
(Date:12/1/2009)...wswire-Asia/ -- Shanghai ChemPartner, as the,flags...ed Contract Research,Organization (CRO), today ann...ogy Fast 50 China, ranking 3rd on the list of the ...award is a testament to ChemPartner,s outstanding,..., The results of the 2009 Deloitte Technology ...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...bryos. , ,This weeks announcement out of Kings Co...d Dolly the sheep, has been granted a license by t...re to spark fresh hopes among disease sufferers, s...iseases as Parkinsons and amyotrophic lateral scle...through research on stem cells, which Wilmut will ...
... venture capital performance in the U.S. during 20...t garnered its share of this investment as well as... had hoped to give you a more detailed look at how...d, that data is not yet out from the Pricewaterhou...to ferret out some additional data on venture capi...
...tronic medical records (EMRs) and images efficient...tself. But offering a seamless view of data across...snugly into the pipe dream file of most CIOs. , ,T.... this week introduced its next general Centricity...em, which it says will allow hospital IT networks ...
Other Biology Technology:Human cloning plans get blessing from British government 2Human cloning plans get blessing from British government 3Midwest VC investment up in 2004, but number of deals down 2Midwest VC investment up in 2004, but number of deals down 3
(Date:12/1/2009)...cularly in Alzheimer,s disease, nerve cell degener...rapeutic options may possibly be derived from stee...ese findings have been published in the current is... Until only a few years ago, neurogenesis the pro...be impossible in the adult brain. The textbooks as...
(Date:12/1/2009)... Georgia Institute of Technology has been awarded ...nostructures for energy harvesting and adaptive ma... cognitive processes of the modern warfighter. ,...enabled Inorganic/Organic Nanostructures and Impro...dimir Tsukruk and Kenneth Sandhage, professors in ...
(Date:12/1/2009)...SVILLE, Fla. Hit-and-run attacks by sharks can be...ulprits by the unique chomp they put on their vict...er and shark expert. , In a method analogous to ...identifications by precisely comparing shark bites...said George Burgess, director of the International...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Reintroduced Chinese alligators now multiplying in the wild in China 9256 1Reintroduced Chinese alligators now multiplying in the wild in China 9256 2Reintroduced Chinese alligators now multiplying in the wild in China 9256 3The Empire State Healthcare Coalition Voices Concern Over the Affordable Health Choices Act 51653 1The Empire State Healthcare Coalition Voices Concern Over the Affordable Health Choices Act 51653 2Pederson Immigration Law Group Attorneys Featured in 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51648 1Pederson Immigration Law Group Attorneys Featured in 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51648 2Pederson Immigration Law Group Attorneys Featured in 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51648 3
...go, as the last ice age was beginning to wane, oft...ctica. , But in a new study led by University of ...s was used as a sort of dipstick to show that a ke... never contained as much ice as scientists origina...ntributed as much to the higher sea level. , In an...
...sity of,Jerusalem have succeeded in discovering an...h special structural and qualitative,characteristi... future,nanocapsules for drug delivery to cancer c...sue, the protein can now,also be produced in large...making it highly available for medicinal or other,...
...ancy, but biologists may soon use it to watch the ... Scientists at the U.S. Department of Energy,s Law...and Lawrence Livermore National Laboratory have de...ll nuclei where they can track life,s fundamental ... "Our work represents the first time a biologist c...
Other Biology News:Ice core 'dipstick' indicates West Antarctic ice has thinned less than believed 2Ice core 'dipstick' indicates West Antarctic ice has thinned less than believed 3The death of a very special chimpanzee 2Nano-Probes Allow an Inside Look at Cell Nuclei 2Nano-Probes Allow an Inside Look at Cell Nuclei 3
...inally formulated to support the growth of cells d...ea eucalypti. The medium is a modification of Wyat...ph. The cell lines established by Grace using this... The basal medium, when properly supplemented, has...
Vsp I from Promega
CERTOMAT U from Sartorius AG
...id, convenient, and efficient Denatured protein co...lute process utilizes a spin column to make handli...roteins which were electro-eluted in their Denatur... offering high binding capacity fo all pH values. ...
Biology Products: